Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Dimerix Limited
  6. News
  7. Summary
    DXB   AU000000DXB7

DIMERIX LIMITED

(DXB)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about DIMERIX LIMITED
01/10Dimerix Doses First Patients in Phase 3 Study of COVID-19 Respiratory Complications Dru..
MT
01/10Dimerix Announces Patients Dosed in DMX-200 COVID-19 Phase 3 Study in India
CI
2021Dimerix Secures Australian Ethics Approval for Phase 3 Study of COVID-19 Drug Candidate..
MT
2021Dimerix Limited Receives Ethics Approval in Australia for Phase 3 Covid-19 Study
CI
2021Dimerix Secures Further Grant Funding for COVID-19 Drug Candidate
MT
2021Dimerix Limited Announces It Has Been Awarded Further AUD 100,000 from the Australian G..
CI
2021Dimerix Limited Advises That 662 Patients Have Now Been Recruited into the Feasibility/..
CI
2021DIMERIX : Notification regarding unquoted securities - DXB
PU
2021DIMERIX : Secures Ethics, Regulatory Approval for Phase 3 Kidney Disease Trial in Australi..
MT
2021Dimerix Limited Announces First Approvals Received for Start of Phase 3 FSGS Trial
CI
2021DIMERIX : Expands Phase 3 Study for COVID-19 Drug to Australia; Shares Rise 4%
MT
2021Dimerix Limited Announces Phase 3 DMX-200 Covid-19 Study Expands into Australia
CI
2021DIMERIX : to Raise $3 Million in Oversubscribed Share Purchase Plan
MT
2021DIMERIX : India's Drug Regulator Approves Dimerix's COVID-19 Drug Clinical Study
MT
2021Dimerix Limited Recommends DMX-200 Clinical Study in COVID-19 Patients
CI
More most relevant news
All news about DIMERIX LIMITED
01/10Dimerix Doses First Patients in Phase 3 Study of COVID-19 Respiratory Complications Dru..
MT
01/10Dimerix Announces Patients Dosed in DMX-200 COVID-19 Phase 3 Study in India
CI
2021Dimerix Secures Australian Ethics Approval for Phase 3 Study of COVID-19 Drug Candidate..
MT
2021Dimerix Limited Receives Ethics Approval in Australia for Phase 3 Covid-19 Study
CI
2021Dimerix Secures Further Grant Funding for COVID-19 Drug Candidate
MT
2021Dimerix Limited Announces It Has Been Awarded Further AUD 100,000 from the Australian G..
CI
2021Dimerix Limited Advises That 662 Patients Have Now Been Recruited into the Feasibility/..
CI
2021DIMERIX : Notification regarding unquoted securities - DXB
PU
2021DIMERIX : Secures Ethics, Regulatory Approval for Phase 3 Kidney Disease Trial in Australi..
MT
2021Dimerix Limited Announces First Approvals Received for Start of Phase 3 FSGS Trial
CI
More news
News in other languages on DIMERIX LIMITED
01/10Dimerix administre les premiers patients de l'étude de phase 3 du COVID-19, un médicame..
01/10Dimerix annonce l'administration de doses à des patients dans le cadre de l'étude de ph..
2021Dimerix obtient l'approbation éthique australienne pour l'étude de phase 3 du candidat ..
2021Dimerix Limited reçoit l'approbation éthique en Australie pour l'étude de phase 3 Covid..
2021Dimerix obtient l'approbation éthique et réglementaire pour un essai de phase 3 sur les..
2021Dimerix étend l'étude de phase 3 du médicament COVID-19 à l'Australie ; les actions aug..
2021Dimerix lève 3 millions de dollars dans le cadre d'un plan d'achat d'actions sursouscri..
2021L'autorité indienne de réglementation des médicaments approuve l'étude clinique du médi..
2021Dimerix lance une étude de phase trois pour les patients atteints de maladies rénales ;..
2021Dimerix creuse sa perte nette pour l'exercice 21 ; les actions bondissent de 43 %.
More news
Press releases
2021DIMERIX : Notification regarding unquoted securities - DXB
PU
2020DIMERIX : DMX-200 Posts Strong Results in Kidney Disease Trial
BU
2019DIMERIX : Holds Pre-IND Meeting on DMX-200 With FDA
PU
More press releases
Upcoming event on DIMERIX LIMITED